The Protection Effect of Speeda® Rabies Vaccine for Human Use

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-02-28

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study was to achieve the post-marketing protective effect research of Speeda® rabies vaccine for human use from Chengda Bio.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use

NCT01821911

Rabies Vaccine Allergy Vaccination Adverse Event Anti-D Antibodies

COMPLETED PHASE4

A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)

NCT04852068

Rabies Vaccine Adverse Reaction Safety and Efficacy

ACTIVE_NOT_RECRUITING PHASE3

Prevention of Rabies With Four Doses of Rabies Vaccine

NCT05545371

Rabies Human Antibody

ENROLLING_BY_INVITATION PHASE3

Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials

NCT06548139

Rabies Virus Infection

NOT_YET_RECRUITING PHASE2

Purified Rabies Vaccine for Human Use (Chick-embryo Cell)

NCT00345319

Rabies Post-exposure Prophylaxis

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

When found the injury who is bitten by the animal to three-level, the investigators would enroll the participant after explaining the protection and making him signed the informed consent. The patient would inject rabies vaccine as follow the national regulation, meanwhile the investigators would get the blood samples to detect whether the man-killer carries the rabies virus.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rabies Vaccine Allergy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

rabies vaccine

When injured by the animal who carries the rabies virus, the patient after standard treatment would survive or die

Group Type EXPERIMENTAL

rabies vaccine

Intervention Type BIOLOGICAL

Injection on day 0、7、21

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

rabies vaccine

Injection on day 0、7、21

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Parent/legal acceptable representatives of children or the adult participants are willing and able to understand the protocol requirements and provide informed consent signed
* Participant is considered to be in good health including the body and mental status on the basis of reported medical history and limited physical examination and live in local ≥ 12 months before injured
* The man-killer could found and detect whether it carries the virus

Exclusion Criteria

* Known bleeding disorder or suspected impairment of immunologic function, or receipt of immunosuppressive therapy or immunoglobulin since birth
* Apply passive immunity preparation

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes